{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:21:24Z","timestamp":1765887684681,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.diabres.2015.01.029","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T14:12:56Z","timestamp":1423750376000},"page":"120-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Glycemic control according to glomerular filtration rate in patients with type 2 diabetes and overt nephropathy: A prospective observational study"],"prefix":"10.1016","volume":"108","author":[{"given":"Dominique","family":"Joly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Choukroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0360-573X","authenticated-orcid":false,"given":"Christian","family":"Combe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Dussol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Fauvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Qu\u00e9r\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Fiquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"February (2)","key":"10.1016\/j.diabres.2015.01.029_bib0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/j.ajkd.2004.09.034","article-title":"Insulin resistance in patients with chronic kidney disease","volume":"45","author":"Kobayashi","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"March (2)","key":"10.1016\/j.diabres.2015.01.029_bib0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1525-139X.2010.00701.x","article-title":"Glycemic control and burnt-out diabetes in ESRD","volume":"23","author":"Kovesdy","year":"2010","journal-title":"Semin Dial"},{"issue":"March (9)","key":"10.1016\/j.diabres.2015.01.029_bib0120","first-page":"818","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes","volume":"364","author":"Gerstein","year":"2011","journal-title":"N Engl J Med"},{"issue":"June (6)","key":"10.1016\/j.diabres.2015.01.029_bib0125","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2215\/CJN.00800209","article-title":"Frequency of hypoglycemia and its significance in chronic kidney disease","volume":"4","author":"Moen","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"December (6)","key":"10.1016\/j.diabres.2015.01.029_bib0130","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.diabet.2012.08.004","article-title":"Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: the ENTRED surveys (2001 and 2007)","volume":"38","author":"Assogba","year":"2012","journal-title":"Diab Metab"},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2015.01.029_bib0135","first-page":"S11","article-title":"Standards of medical care in diabetes \u2013 2012","volume":"35","year":"2012","journal-title":"Diab Care"},{"issue":"September (9131)","key":"10.1016\/j.diabres.2015.01.029_bib0140","first-page":"837","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"October (15)","key":"10.1016\/j.diabres.2015.01.029_bib0145","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"November (21)","key":"10.1016\/j.diabres.2015.01.029_bib0150","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/archinternmed.2010.409","article-title":"Metformin use and mortality among patients with diabetes and atherothrombosis","volume":"170","author":"Roussel","year":"2010","journal-title":"Arch Intern Med"},{"issue":"November (11)","key":"10.1016\/j.diabres.2015.01.029_bib0155","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dc08-1171","article-title":"Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis","volume":"31","author":"Bodmer","year":"2008","journal-title":"Diab Care"},{"issue":"April (8)","key":"10.1016\/j.diabres.2015.01.029_bib0160","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5694\/j.1326-5377.2008.tb01713.x","article-title":"Metformin lactic acidosis in an Australian community setting: the Fremantle Diabetes Study","volume":"188","author":"Kamber","year":"2008","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.diabres.2015.01.029_bib0165","first-page":"CD002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","author":"Salpeter","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.diabres.2015.01.029_bib0170","first-page":"CD002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","author":"Salpeter","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"January (1)","key":"10.1016\/j.diabres.2015.01.029_bib0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2337\/diacare.22.1.38","article-title":"First 20 months\u2019 experience with use of metformin for type 2 diabetes in a large health maintenance organization","volume":"22","author":"Selby","year":"1999","journal-title":"Diab Care"},{"issue":"November (11)","key":"10.1016\/j.diabres.2015.01.029_bib0180","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/j.1552-4604.1995.tb04033.x","article-title":"Kidney function and age are both predictors of pharmacokinetics of metformin","volume":"35","author":"Sambol","year":"1995","journal-title":"J Clin Pharmacol"},{"issue":"September (Suppl. 2)","key":"10.1016\/j.diabres.2015.01.029_bib0185","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1262-3636(11)70961-2","article-title":"Expert consensus on management of diabetic patients with impairment of renal function","volume":"37","author":"Bonnet","year":"2011","journal-title":"Diab Metab"},{"issue":"August (5)","key":"10.1016\/j.diabres.2015.01.029_bib0190","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1503\/cmaj.045292","article-title":"Metformin's contraindications should be contraindicated","volume":"173","author":"McCormack","year":"2005","journal-title":"Can Med Assoc J"},{"issue":"December (12)","key":"10.1016\/j.diabres.2015.01.029_bib0195","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1463-1326.2010.01295.x","article-title":"Limitations of metformin use in patients with kidney disease: are they warranted?","volume":"12","author":"Vasisht","year":"2010","journal-title":"Diab Obes Metab"},{"issue":"December (Suppl. 3)","key":"10.1016\/j.diabres.2015.01.029_bib0200","doi-asserted-by":"crossref","first-page":"C35","DOI":"10.2337\/diacare.21.3.C35","article-title":"Prospective diabetes study. A review","volume":"21","author":"Turner","year":"1998","journal-title":"Diab Care"},{"issue":"July (7)","key":"10.1016\/j.diabres.2015.01.029_bib0205","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/diacare.27.7.1535","article-title":"The burden of treatment failure in type 2 diabetes","volume":"27","author":"Brown","year":"2004","journal-title":"Diab Care"},{"issue":"July (4)","key":"10.1016\/j.diabres.2015.01.029_bib0210","first-page":"512","article-title":"Frequency of HbA1c discordance in estimating blood glucose control","volume":"11","author":"Cohen","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822715000492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822715000492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:06:03Z","timestamp":1759172763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822715000492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0168822715000492"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2015.01.029","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycemic control according to glomerular filtration rate in patients with type 2 diabetes and overt nephropathy: A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2015.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}